ReviewJournal of neuro-oncology2009

Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Scott R Plotkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.